158 related articles for article (PubMed ID: 33524275)
1. Lack of longitudinal changes in cognition in individuals with methamphetamine use disorder during the first 6 weeks after commencing treatment.
Fitzpatrick RE; Robinson AH; Rubenis AJ; Lubman DI; Verdejo-Garcia A
Am J Drug Alcohol Abuse; 2021 May; 47(3):383-392. PubMed ID: 33524275
[No Abstract] [Full Text] [Related]
2. Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence.
Fitzpatrick RE; Rubenis AJ; Lubman DI; Verdejo-Garcia A
Drug Alcohol Depend; 2020 Apr; 209():107891. PubMed ID: 32061948
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
[TBL] [Abstract][Full Text] [Related]
4. Working memory predicts methamphetamine hair concentration over the course of treatment: moderating effect of impulsivity and implications for dual-systems model.
Rubenis AJ; Fitzpatrick RE; Lubman DI; Verdejo-Garcia A
Addict Biol; 2019 Jan; 24(1):145-153. PubMed ID: 29114992
[TBL] [Abstract][Full Text] [Related]
5. Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.
Potvin S; Pelletier J; Grot S; Hébert C; Barr AM; Lecomte T
Addict Behav; 2018 May; 80():154-160. PubMed ID: 29407687
[TBL] [Abstract][Full Text] [Related]
6. The effect of relapse on cognition in abstinent methamphetamine abusers.
Simon SL; Dacey J; Glynn S; Rawson R; Ling W
J Subst Abuse Treat; 2004 Jul; 27(1):59-66. PubMed ID: 15223095
[TBL] [Abstract][Full Text] [Related]
7. The impact of cognitive training in substance use disorder: the effect of working memory training on impulse control in methamphetamine users.
Brooks SJ; Wiemerslage L; Burch KH; Maiorana SA; Cocolas E; Schiöth HB; Kamaloodien K; Stein DJ
Psychopharmacology (Berl); 2017 Jun; 234(12):1911-1921. PubMed ID: 28324119
[TBL] [Abstract][Full Text] [Related]
8. Impulsivity predicts poorer improvement in quality of life during early treatment for people with methamphetamine dependence.
Rubenis AJ; Fitzpatrick RE; Lubman DI; Verdejo-Garcia A
Addiction; 2018 Apr; 113(4):668-676. PubMed ID: 28987070
[TBL] [Abstract][Full Text] [Related]
9. Cue Exposure Triggers Inhibitory Deficits in Individuals With Methamphetamine Use Disorder.
He X; Zhao D; Zhang M; Leng Y; He W
J Stud Alcohol Drugs; 2021 Mar; 82(2):197-203. PubMed ID: 33823966
[TBL] [Abstract][Full Text] [Related]
10. Increased self-reported impulsivity in methamphetamine users maintaining drug abstinence.
Jones HW; Dean AC; Price KA; London ED
Am J Drug Alcohol Abuse; 2016 Sep; 42(5):500-506. PubMed ID: 27398730
[TBL] [Abstract][Full Text] [Related]
11. Higher impulsivity and lower grey matter volume in the bilateral prefrontal cortex in long-term abstinent individuals with severe methamphetamine use disorder.
Huang S; Dai Y; Zhang C; Yang C; Huang Q; Hao W; Shen H
Drug Alcohol Depend; 2020 Jul; 212():108040. PubMed ID: 32428790
[TBL] [Abstract][Full Text] [Related]
12. Sustained attention but not effort-based decision-making predicts treatment motivation change in people with methamphetamine dependence.
Rubenis AJ; Fitzpatrick RE; Lubman DI; Verdejo-Garcia A
J Subst Abuse Treat; 2018 Dec; 95():48-54. PubMed ID: 30352670
[TBL] [Abstract][Full Text] [Related]
13. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.
Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I;
J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.
Dean AC; Nurmi EL; Morales AM; Cho AK; Seaman LC; London ED
Addict Biol; 2021 May; 26(3):e12950. PubMed ID: 32767519
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in impulsivity and brain morphometry in methamphetamine users.
Kogachi S; Chang L; Alicata D; Cunningham E; Ernst T
Brain Struct Funct; 2017 Jan; 222(1):215-227. PubMed ID: 27095357
[TBL] [Abstract][Full Text] [Related]
16. A Newly Designed Mobile-Based Computerized Cognitive Addiction Therapy App for the Improvement of Cognition Impairments and Risk Decision Making in Methamphetamine Use Disorder: Randomized Controlled Trial.
Zhu Y; Jiang H; Su H; Zhong N; Li R; Li X; Chen T; Tan H; Du J; Xu D; Yan H; Xu D; Zhao M
JMIR Mhealth Uhealth; 2018 Jun; 6(6):e10292. PubMed ID: 29925497
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence.
Stock AK; Rädle M; Beste C
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():41-52. PubMed ID: 29953935
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
Chen YC; Wang LJ; Lin SK; Chen CK
Subst Use Misuse; 2015; 50(14):1778-85. PubMed ID: 26625283
[TBL] [Abstract][Full Text] [Related]
19. The interplay of childhood trauma, oxytocin, and impulsivity in predicting the onset of methamphetamine use.
Chang HM; Chen C; Lu ML; Jou S; Santos VHJ; Goh KK
Child Abuse Negl; 2024 Jan; 147():106579. PubMed ID: 38048654
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.
Manning V; Garfield JBB; Mroz K; Campbell SC; Piercy H; Staiger PK; Lum JAG; Lubman DI; Verdejo-Garcia A
J Subst Abuse Treat; 2019 Nov; 106():12-18. PubMed ID: 31540606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
